Skandinaviska Enskilda Banken (SEB)’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17,500
Closed -$625K 802
2023
Q4
$625K Buy
17,500
+4,300
+33% +$160K ﹤0.01% 757
2023
Q3
$578K Buy
13,200
+200
+2% +$9.76K ﹤0.01% 745
2023
Q2
$642K Sell
13,000
-3,000
-19% -$138K ﹤0.01% 759
2023
Q1
$663K Buy
+16,000
New +$664K ﹤0.01% 742
2021
Q2
Sell
-8,100
Closed -$531K 1051
2021
Q1
$531K Hold
8,100
﹤0.01% 921
2020
Q4
$451K Buy
8,100
+2,500
+45% +$108K ﹤0.01% 926
2020
Q3
$223K Buy
+5,600
New +$237K ﹤0.01% 903

Other funds holding ATRC

Skandinaviska Enskilda Banken (SEB)'s ATRC Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 17,500 shares — an estimated $625K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ATRC in Q3 2020 and held it in 7 quarters. The position peaked at $663K in Q1 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 17,500 AtriCure shares in Q1 2024, an estimated $625K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in AtriCure in Q3 2020 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s AtriCure position peaked at $663K in Q1 2023.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.